What is the management of maternal fever during labor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Maternal Fever During Labor

Maternal fever during labor (≥38.0°C/100.4°F) should be promptly treated with broad-spectrum intrapartum antibiotics—specifically ampicillin (2g IV initial dose, then 1g IV every 4 hours) plus gentamicin (weight-based dosing)—while simultaneously investigating for chorioamnionitis and other infectious causes. 1

Diagnostic Approach

Clinical diagnosis of chorioamnionitis requires maternal fever (≥38.0°C) PLUS at least one additional finding: 1, 2

  • Maternal tachycardia
  • Fetal tachycardia
  • Uterine tenderness
  • Foul-smelling amniotic fluid
  • Maternal leukocytosis

Important caveat: Epidural analgesia causes fever in 15-25% of patients through a sterile inflammatory process, making it the strongest risk factor for intrapartum fever (adjusted odds ratio 5.5). 3, 4 However, do not delay antibiotic treatment while attempting to distinguish epidural-related fever from infectious causes, as this distinction cannot be made reliably at the bedside. 4

Antibiotic Management

Standard regimen (no penicillin allergy): 1

  • Ampicillin 2g IV initial dose, then 1g IV every 4 hours until delivery
  • PLUS Gentamicin (loading dose followed by weight-based maintenance dosing)

Non-severe penicillin allergy: 1, 2

  • Cefazolin 2g IV initial dose, then 1g IV every 8 hours until delivery
  • PLUS Gentamicin

Severe penicillin allergy: 1, 2

  • Clindamycin 900mg IV every 8 hours OR Vancomycin 1g IV every 12 hours until delivery
  • PLUS Gentamicin

Timing is critical: Antibiotics should be initiated within 3 hours of fever recognition, or within 1 hour if septic shock is suspected. 5 Blood cultures should be obtained before antibiotic administration when feasible. 5

Maternal Benefits and Risks

Antibiotic treatment reduces: 6

  • Postpartum fever (adjusted odds ratio 0.42)
  • Treatment for postpartum endometritis (3.53% vs 11.31% without antibiotics)

Labor management considerations: 7

  • Intrapartum fever increases risk of cesarean delivery by 2-3 fold due to impaired uterine contractility
  • Fever increases postpartum hemorrhage risk by 2-3 fold
  • Have uterotonic agents immediately available at delivery to prevent treatment delays 7
  • Fever itself is NOT an indication for cesarean delivery to improve neonatal outcomes 7

Neonatal Management

Well-appearing newborns born to mothers with chorioamnionitis require: 1, 2

  • Limited evaluation: blood culture and CBC with differential
  • Empirical antibiotic therapy (IV ampicillin for GBS coverage) pending culture results

Newborns with signs of sepsis require: 1

  • Full diagnostic evaluation: blood culture, CBC with differential, chest radiograph if respiratory symptoms, lumbar puncture if stable
  • Empirical broad-spectrum antibiotics including IV ampicillin (for GBS and E. coli coverage)

Critical context: The actual risk of early-onset neonatal sepsis in term infants born to febrile mothers is low at 0.24% (1 in 417). 8 However, maternal fever >39°C increases neonatal encephalopathy risk (4.4% vs 1.1% with fever 38-39°C), particularly when combined with fetal acidosis. 7 This justifies the precautionary approach to neonatal evaluation and treatment.

Adjunctive Measures

Acetaminophen: May be administered but has limited efficacy in reducing maternal temperature once fever develops. 7 A non-significant trend toward decreased failure to progress was noted with acetaminophen use. 3

Avoid hyperthermia: The goal is normothermia, as hyperthermia adversely impacts uterine contractility and may lower the threshold for fetal hypoxic brain injury. 5, 7

Prevention Strategies

Reducing fever incidence: 7

  • Maintain labor progress through active management
  • High-dose oxytocin regimen (6×6 mU/min vs 2×2 mU/min) reduced intrapartum fever rates from 15.6% to 10.4%
  • Duration of epidural exposure and prolonged labor are modifiable risk factors

Risk factors to monitor: 3

  • Epidural analgesia (strongest association)
  • Prolonged second stage of labor
  • Prolonged rupture of membranes
  • Meconium-stained amniotic fluid

Common Pitfalls

  • Do not withhold antibiotics pending amniocentesis results or waiting for maternal fever to develop in suspected chorioamnionitis 5
  • Do not perform cesarean delivery solely to reduce fetal exposure to fever—there is no evidence this improves neonatal outcomes 7
  • Do not assume epidural-related fever is benign—treat all intrapartum fevers as potentially infectious until proven otherwise 4
  • Be prepared for postpartum hemorrhage—have multiple uterotonic agents ready at delivery 7

References

Guideline

Chorioamnionitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oxytocin Use in Chorioamnionitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fever in term labour.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2005

Research

Epidural-related maternal fever: incidence, pathophysiology, outcomes, and management.

American journal of obstetrics and gynecology, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Maternal fever in labor: etiologies, consequences, and clinical management.

American journal of obstetrics and gynecology, 2023

Research

Incidence of fever in labor and risk of neonatal sepsis.

American journal of obstetrics and gynecology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.